4,393
Views
150
CrossRef citations to date
0
Altmetric
SPECIAL FOCUS: RNA Vaccines - Review

Lipid-based mRNA vaccine delivery systems

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Wubetu Yihunie, Getinet Nibret & Yibeltal Aschale. (2023) Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review. Clinical Pharmacology: Advances and Applications 15, pages 77-98.
Read now
Akon Higuchi, Tzu-Cheng Sung, Ting Wang, Qing-Dong Ling, S. Suresh Kumar, Shih-Tien Hsu & Akihiro Umezawa. (2023) Material Design for Next-Generation mRNA Vaccines Using Lipid Nanoparticles. Polymer Reviews 63:2, pages 394-436.
Read now
Dylan A. Hendy, Alex Haven, Eric M. Bachelder & Kristy M. Ainslie. (2023) Preclinical developments in the delivery of protein antigens for vaccination. Expert Opinion on Drug Delivery 20:3, pages 367-384.
Read now
Xueyan Zhang, Ke Men, Yuanfa Zhang, Rui Zhang, Li Yang & Xingmei Duan. (2019) Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy. International Journal of Nanomedicine 14, pages 2733-2751.
Read now

Articles from other publishers (146)

Qimanguli Saiding, Zhongyang Zhang, Shuying Chen, Fan Xiao, Yumeng Chen, Yongjiang Li, Xueyan Zhen, Muhammad Muzamil Khan, Wei Chen, Seyoung Koo, Na Kong & Wei Tao. (2023) Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery. Advanced Drug Delivery Reviews 203, pages 115116.
Crossref
Yanira Zeyn, Dominika Hobernik, Ulrich Wilk, Jana Pöhmerer, Christoph Hieber, Carolina Medina-Montano, Nadine Röhrig, Caroline F. Strähle, Andrea K. Thoma-Kress, Ernst Wagner, Matthias Bros & Simone Berger. (2023) Transcriptional Targeting of Dendritic Cells Using an Optimized Human Fascin1 Gene Promoter. International Journal of Molecular Sciences 24:23, pages 16938.
Crossref
Christophe Delehedde, Ivan Ciganek, Nathalie Rameix, Nabila Laroui, Cristine Gonçalves, Luc Even, Patrick Midoux & Chantal Pichon. (2023) Impact of net charge, targeting ligand amount and mRNA modification on the uptake, intracellular routing and the transfection efficiency of mRNA lipopolyplexes in dendritic cells. International Journal of Pharmaceutics 647, pages 123531.
Crossref
Chenghai Bai, Chen Wang & Yuan Lu. (2023) Novel Vectors and Administrations for mRNA Delivery. Small 19:46.
Crossref
Yiming Cao, Jinrong Long, Huisheng Sun, Yiqi Miao, Ye Sang, Haitao Lu, Changxiao Yu, Zhen Zhang, Lin Wang, Jing Yang & Shengqi Wang. (2023) Dendritic Cell‐Mimicking Nanoparticles Promote mRNA Delivery to Lymphoid Organs. Advanced Science 10:33.
Crossref
Jean-Philippe SPANO. (2023) Les perspectives de l’ARN messager en oncologie. Actualités Pharmaceutiques 62:629, pages S19-S21.
Crossref
Dun Niu, Yaran Wu & Jiqin Lian. (2023) Circular RNA vaccine in disease prevention and treatment. Signal Transduction and Targeted Therapy 8:1.
Crossref
Anne Galy, Ben Berkhout, Karine Breckpot, Chantal Pichon, Kristie Bloom, Hans-Peter Kiem, Michael D. Mühlebach & Joseph M. McCune. (2023) Recent Advances Using Genetic Therapies Against Infectious Diseases and for Vaccination. Human Gene Therapy 34:17-18, pages 896-904.
Crossref
Satyendra Prakash. (2023) mRNA-Based Nanomedicine: A New Strategy for Treating Infectious Diseases and Beyond. European Journal of Drug Metabolism and Pharmacokinetics 48:5, pages 515-529.
Crossref
Yousef Khazaei Monfared, Mohammad Mahmoudian, Parvin Zakeri-Milani, Claudio Cecone, Tomoya Hayashi, Ken J. Ishii, João Conde, Adrián Matencio & Francesco Trotta. (2023) Intratumoural Delivery of mRNA Loaded on a Cationic Hyper-Branched Cyclodextrin-Based Polymer Induced an Anti-Tumour Immunological Response in Melanoma. Cancers 15:14, pages 3748.
Crossref
Xiaolin Xu, Wencai Guan, Xiaolei Yu, Guoxiong Xu & Chenglong Wang. (2023) Non-interfacial self-assembly of synthetic protocells. Biomaterials Research 27:1.
Crossref
Zhe Wang, Wanting Ma, Xingxing Fu, Yanfei Qi, Yinan Zhao & Shubiao Zhang. (2023) Development and applications of mRNA treatment based on lipid nanoparticles. Biotechnology Advances 65, pages 108130.
Crossref
Azam Bolhassani. (2022) Lipid-Based Delivery Systems in Development of Genetic and Subunit Vaccines. Molecular Biotechnology 65:5, pages 669-698.
Crossref
Lei Peng, Quan Xu, Sui Yin, Ye Zhang, Hao Wu, Yangchun Liu, Liru Chen, Yeji Hu, Jun Yuan, Kai Peng & Qin Lin. (2023) The emerging nanomedicine-based technology for non-small cell lung cancer immunotherapy: how far are we from an effective treatment. Frontiers in Oncology 13.
Crossref
Sarfaraz K. Niazi. (2023) RNA Therapeutics: A Healthcare Paradigm Shift. Biomedicines 11:5, pages 1275.
Crossref
Bharathi Karunakaran, Raghav Gupta, Pranav Patel, Sagar Salave, Amit Sharma, Dhruv Desai, Derajram Benival & Nagavendra Kommineni. (2023) Emerging Trends in Lipid-Based Vaccine Delivery: A Special Focus on Developmental Strategies, Fabrication Methods, and Applications. Vaccines 11:3, pages 661.
Crossref
Vanessa A. Zirkenbach, Rebecca M. Ignatz, Renate Öttl, Zeynep Cehreli, Vera Stroikova, Mansur Kaya, Lorenz H. Lehmann, Michael R. Preusch, Norbert Frey & Ziya Kaya. (2023) Effect of SARS-CoV-2 mRNA-Vaccine on the Induction of Myocarditis in Different Murine Animal Models. International Journal of Molecular Sciences 24:5, pages 5011.
Crossref
Allegra Peletta, Céline Lemoine, Thomas Courant, Nicolas Collin & Gerrit Borchard. (2023) Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines. Pharmacological Research 189, pages 106699.
Crossref
He Xian, Yue Zhang, Chengzhong Yu & Yue Wang. (2023) Nanobiotechnology-Enabled mRNA Stabilization. Pharmaceutics 15:2, pages 620.
Crossref
Aisha Farhana. (2023) Enhancing Skin Cancer Immunotheranostics and Precision Medicine through Functionalized Nanomodulators and Nanosensors: Recent Development and Prospects. International Journal of Molecular Sciences 24:4, pages 3493.
Crossref
Christin Schmidt & Barbara S. Schnierle. (2023) Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development. Pathogens 12:1, pages 138.
Crossref
Simone Pecetta, S. Sohail Ahmed, Ronald Ellis & Rino Rappuoli. 2023. Plotkin's Vaccines. Plotkin's Vaccines 1350 1373.e9 .
Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines 325 530 .
Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines 1 32 .
Wenjie Zhang, Reza Taheri-Ledari, Fatemeh Ganjali, Seyedeh Shadi Mirmohammadi, Fateme Sadat Qazi, Mahdi Saeidirad, Amir KashtiAray, Simindokht Zarei-Shokat, Ye Tian & Ali Maleki. (2023) Effects of morphology and size of nanoscale drug carriers on cellular uptake and internalization process: a review. RSC Advances 13:1, pages 80-114.
Crossref
Ishita N. Waghela, Katherine L. Mallory, Justin A. Taylor, Cosette G. Schneider, Tatyana Savransky, Chris J. Janse, Paulo J. C. Lin, Ying K. Tam, Drew Weissman & Evelina Angov. (2022) Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS. Frontiers in Immunology 13.
Crossref
Alanne Rayssa da Silva Melo, Larissa Silva de Macêdo, Maria da Conceição Viana Invenção, Ingrid Andrêssa de Moura, Marco Antonio Turiah Machado da Gama, Cristiane Moutinho Lagos de Melo, Anna Jéssica Duarte Silva, Marcus Vinicius de Aragão Batista & Antonio Carlos de Freitas. (2022) Third-Generation Vaccines: Features of Nucleic Acid Vaccines and Strategies to Improve Their Efficiency. Genes 13:12, pages 2287.
Crossref
Akbar Hasanzadeh, Michael R. Hamblin, Jafar Kiani, Hamid Noori, Joseph M. Hardie, Mahdi Karimi & Hadi Shafiee. (2022) Could artificial intelligence revolutionize the development of nanovectors for gene therapy and mRNA vaccines?. Nano Today 47, pages 101665.
Crossref
Mahtab Ghasemi Toudeshkchouei, Atefeh Tavakoli, Hossein Mohammadghasemi, Anita Karimi, Jafar Ai, Mohammad Rabiee & Navid Rabiee. (2022) Recent approaches to mRNA vaccine delivery by lipid-based vectors prepared by continuous-flow microfluidic devices. Future Medicinal Chemistry 14:21, pages 1561-1581.
Crossref
Wanting Zhang, Yuxin Jiang, Yonglong He, Hamza Boucetta, Jun Wu, Zhongjian Chen & Wei He. (2022) Lipid carriers for mRNA delivery. Acta Pharmaceutica Sinica B.
Crossref
Hossein Hosseinkhani. 2022. Biomedical Engineering. Biomedical Engineering 209 254 .
Ting Liu, Yang Tian, Aiping Zheng & Chunying Cui. (2022) Design Strategies for and Stability of mRNA–Lipid Nanoparticle COVID-19 Vaccines. Polymers 14:19, pages 4195.
Crossref
Cathrine Lund Lorentzen, John B Haanen, Özcan Met & Inge Marie Svane. (2022) Clinical advances and ongoing trials on mRNA vaccines for cancer treatment. The Lancet Oncology 23:10, pages e450-e458.
Crossref
Isabel Acosta-Coley, Leonor Cervantes-Ceballos, Lesly Tejeda-Benítez, Lucellys Sierra-Márquez, María Cabarcas-Montalvo, María García-Espiñeira, Wilfrido Coronell-Rodríguez & Bárbara Arroyo-Salgado. (2022) Vaccines platforms and COVID-19: what you need to know. Tropical Diseases, Travel Medicine and Vaccines 8:1.
Crossref
Ketaki ShindeSonam BendreNiraj KaleSuhit Gilda. (2022) The mRNA Vaccine Heralds a New Era in Vaccinology. Asian Journal of Pharmacy and Technology, pages 257-265.
Crossref
Dania Grant-Serroukh, Morag R. Hunter, Ruhina Maeshima, Aristides D. Tagalakis, Ahmad M. Aldossary, Nour Allahham, Gareth R. Williams, Mark Edbrooke, Arpan Desai & Stephen L. Hart. (2022) Lipid-peptide nanocomplexes for mRNA delivery in vitro and in vivo. Journal of Controlled Release 348, pages 786-797.
Crossref
Tânia R. Dias, Francisca Dias, Ana Luísa Teixeira, Hugo Sousa, Júlio Oliveira & Rui Medeiros. (2022) MicroRNAs as Potential Tools for Predicting Cancer Patients’ Susceptibility to SARS-CoV-2 Infection and Vaccination Response. Cells 11:15, pages 2279.
Crossref
Xiang Yu, Hai Xiao, Muqier Muqier, Shuqin Han & Huricha Baigude. (2022) Effect of the array of amines on the transfection efficiency of cationic peptidomimetic lipid molecules into neural cells. RSC Advances 12:33, pages 21567-21573.
Crossref
Sigrid D’haese, Thessa Laeremans, Sabine Roover, Sabine Allard, Guido Vanham & Joeri Aerts. (2022) Efficient Induction of Antigen-Specific CD8+ T-Cell Responses by Cationic Peptide-Based mRNA Nanoparticles. Pharmaceutics 14:7, pages 1387.
Crossref
Randall A. Meyer, Sarah Y. Neshat, Jordan J. Green, Jose Luis Santos & Anthony D. Tuesca. (2022) Targeting strategies for mRNA delivery. Materials Today Advances 14, pages 100240.
Crossref
Shugang Qin, Xiaoshan Tang, Yuting Chen, Kepan Chen, Na Fan, Wen Xiao, Qian Zheng, Guohong Li, Yuqing Teng, Min Wu & Xiangrong Song. (2022) mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduction and Targeted Therapy 7:1.
Crossref
Abid Hussain, Haiyin Yang, Mengjie Zhang, Qing Liu, Ghallab Alotaibi, Muhammad Irfan, Huining He, Jin Chang, Xing-Jie Liang, Yuhua Weng & Yuanyu Huang. (2022) mRNA vaccines for COVID-19 and diverse diseases. Journal of Controlled Release 345, pages 314-333.
Crossref
Wang Chen, Yonghui Ma, Xiaoxuan Liu & Dandan Zhu. (2022) Polyester materials for mRNA delivery. Exploration of Targeted Anti-tumor Therapy, pages 117-127.
Crossref
Mengyun Li, Zining Wang, Chunyuan Xie & Xiaojun Xia. 2022. mRNA-Based Therapeutics. mRNA-Based Therapeutics 295 316 .
Andreas Ouranidis, Theofanis Vavilis, Evdokia Mandala, Christina Davidopoulou, Eleni Stamoula, Catherine K. Markopoulou, Anna Karagianni & Kyriakos Kachrimanis. (2021) mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles. Biomedicines 10:1, pages 50.
Crossref
Bruno Baptista, Rita Carapito, Nabila Laroui, Chantal Pichon & Fani Sousa. (2021) mRNA, a Revolution in Biomedicine. Pharmaceutics 13:12, pages 2090.
Crossref
Lei Li, Jinrong Long, Ye Sang, Xin Wang, Xinyang Zhou, Yufei Pan, Yiming Cao, Huiyuan Huang, Zhenjun Yang, Jing Yang & Shengqi Wang. (2021) Rational preparation and application of a mRNA delivery system with cytidinyl/cationic lipid. Journal of Controlled Release 340, pages 114-124.
Crossref
Takshveer Singh, Mortaza Fatehi Hassanabad & Ali Fatehi Hassanabad. (2021) Non-small cell lung cancer: Emerging molecular targeted and immunotherapeutic agents. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:2, pages 188636.
Crossref
Andaleeb Sajid, Jaqueline Matias, Gunjan Arora, Cheyne KurokawaKathleen DePonteXiaotian Tang, Geoffrey Lynn, Ming-Jie WuUtpal Pal, Norma Olivares StrankNorbert Pardi, Sukanya Narasimhan, Drew Weissman & Erol Fikrig. (2021) mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent. Science Translational Medicine 13:620.
Crossref
Ana Krhač Levačić, Simone Berger, Judith Müller, Andrea Wegner, Ulrich Lächelt, Christian Dohmen, Carsten Rudolph & Ernst Wagner. (2021) Dynamic mRNA polyplexes benefit from bioreducible cleavage sites for in vitro and in vivo transfer. Journal of Controlled Release 339, pages 27-40.
Crossref
Yuebao Zhang, Changzhen Sun, Chang Wang, Katarina E. Jankovic & Yizhou Dong. (2021) Lipids and Lipid Derivatives for RNA Delivery. Chemical Reviews 121:20, pages 12181-12277.
Crossref
Michal Monselise, Chia-Hsuan Chang, Gustavo Ferreira, Rita Yang & Christopher C Yang. (2021) Topics and Sentiments of Public Concerns Regarding COVID-19 Vaccines: Social Media Trend Analysis. Journal of Medical Internet Research 23:10, pages e30765.
Crossref
Hana M. Abdelzaher, Asmaa S. Gabr, Basma M. Saleh, Rana M. Abdel Gawad, Ahmed A. Nour & Anwar Abdelanser. (2021) RNA Vaccines against Infectious Diseases: Vital Progress with Room for Improvement. Vaccines 9:11, pages 1211.
Crossref
Miriam Simon, Michael Veit, Klaus Osterrieder & Michael Gradzielski. (2021) Surfactants – Compounds for inactivation of SARS-CoV-2 and other enveloped viruses. Current Opinion in Colloid & Interface Science 55, pages 101479.
Crossref
Javier T. Granados-Riveron & Guillermo Aquino-Jarquin. (2021) Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2. Biomedicine & Pharmacotherapy 142, pages 111953.
Crossref
Maryam Bidram, Yue Zhao, Natalia G. Shebardina, Alexey V. Baldin, Alexandr V. Bazhin, Mohamad Reza Ganjalikhany, Andrey A. ZamyatninJr.Jr. & Mazdak Ganjalikhani-hakemi. (2021) mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients. Vaccines 9:10, pages 1060.
Crossref
Jason L. Andresen & Owen S. Fenton. (2021) Nucleic acid delivery and nanoparticle design for COVID vaccines. MRS Bulletin 46:9, pages 832-839.
Crossref
Emily A. Voigt, Jasmine Fuerte-Stone, Brian Granger, Jacob Archer & Neal Van Hoeven. (2021) Live-attenuated RNA hybrid vaccine technology provides single-dose protection against Chikungunya virus. Molecular Therapy 29:9, pages 2782-2793.
Crossref
B. Baptista, M. Riscado, J.A. Queiroz, C. Pichon & F. Sousa. (2021) Non-coding RNAs: Emerging from the discovery to therapeutic applications. Biochemical Pharmacology 189, pages 114469.
Crossref
Christophe Delehedde, Luc Even, Patrick Midoux, Chantal Pichon & Federico Perche. (2021) Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles. Pharmaceutics 13:7, pages 945.
Crossref
Katherine L. Mallory, Justin A. Taylor, Xiaoyan Zou, Ishita N. Waghela, Cosette G. Schneider, Michael Q. Sibilo, Neeraja M. Punde, Leah C. Perazzo, Tatyana Savransky, Martha Sedegah, Sheetij Dutta, Chris J. Janse, Norbert Pardi, Paulo J. C. Lin, Ying K. Tam, Drew Weissman & Evelina Angov. (2021) Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice. npj Vaccines 6:1.
Crossref
Christopher P. Baryiames, Paul Garrett & Carlos R. Baiz. (2021) Bursting the bubble: A molecular understanding of surfactant-water interfaces. The Journal of Chemical Physics 154:17.
Crossref
Ehsan Raoufi, Bahar Bahramimeimandi, M. Salehi-Shadkami, Patcharida Chaosri & M. R. Mozafari. (2021) Methodical Design of Viral Vaccines Based on Avant-Garde Nanocarriers: A Multi-Domain Narrative Review. Biomedicines 9:5, pages 520.
Crossref
Hermann AM Mucke. (2021) Patent highlights December 2020–January 2021. Pharmaceutical Patent Analyst 10:3, pages 103-110.
Crossref
Hector Teran-Navarro, David Salcines-Cuevas, Ricardo Calderon-Gonzalez, Raquel Tobes, Jorge Calvo-Montes, Inmaculada Concepción Pérez-Del Molino Bernal, Sonsoles Yañez-Diaz, Manuel Fresno & Carmen Alvarez-Dominguez. (2021) A Comparison Between Recombinant Listeria GAPDH Proteins and GAPDH Encoding mRNA Conjugated to Lipids as Cross-Reactive Vaccines for Listeria, Mycobacterium, and Streptococcus. Frontiers in Immunology 12.
Crossref
Thai Thanh Hoang Thi, Estelle J. A. Suys, Jung Seok Lee, Dai Hai Nguyen, Ki Dong Park & Nghia P. Truong. (2021) Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines. Vaccines 9:4, pages 359.
Crossref
Annkristin Heine, Stefan Juranek & Peter Brossart. (2021) Clinical and immunological effects of mRNA vaccines in malignant diseases. Molecular Cancer 20:1.
Crossref
Md. Motiar Rahman, Nan Zhou & Jiandong Huang. (2021) An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo. Vaccines 9:3, pages 244.
Crossref
Federica Ponti, Matilde Campolungo, Clara Melchiori, Nina Bono & Gabriele Candiani. (2021) Cationic lipids for gene delivery: many players, one goal. Chemistry and Physics of Lipids 235, pages 105032.
Crossref
Deborah Pushparajah, Salma Jimenez, Shirley Wong, Hibah Alattas, Nafiseh Nafissi & Roderick A. Slavcev. (2021) Advances in gene-based vaccine platforms to address the COVID-19 pandemic. Advanced Drug Delivery Reviews 170, pages 113-141.
Crossref
Zimei Wu & Tonglei Li. (2021) Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives. Pharmaceutical Research 38:3, pages 473-478.
Crossref
Mingming Song, Chang Liu, Siyu Chen & Wenxiang Zhang. (2021) Nanocarrier-Based Drug Delivery for Melanoma Therapeutics. International Journal of Molecular Sciences 22:4, pages 1873.
Crossref
Basmah N. Aldosari, Iman M. Alfagih & Alanood S. Almurshedi. (2021) Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines. Pharmaceutics 13:2, pages 206.
Crossref
Mi Tian, Tao Wang & Peng Wang. (2021) Development and Clinical Validation of a Seven-Gene Prognostic Signature Based on Multiple Machine Learning Algorithms in Kidney Cancer. Cell Transplantation 30, pages 096368972096917.
Crossref
Paramita Mandal, Anindita Goswami, Sarmistha Adhikari & Subham Sarkar. 2021. Targeting Cellular Signalling Pathways in Lung Diseases. Targeting Cellular Signalling Pathways in Lung Diseases 241 261 .
Chaoyang Meng, Zhe Chen, Gang Li, Thomas Welte & Haifa Shen. (2020) Nanoplatforms for mRNA Therapeutics. Advanced Therapeutics 4:1, pages 2000099.
Crossref
Iman M. Alfagih, Basmah Aldosari, Bushra AlQuadeib, Alanood Almurshedi & Mariyam M. Alfagih. (2020) Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines. Pharmaceutics 13:1, pages 45.
Crossref
Lien Van Hoecke, Kenny Roose, Marlies Ballegeer, Zifu Zhong, Niek N. Sanders, Stefaan De Koker, Xavier Saelens & Sandra Van Lint. (2020) The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration. Molecular Therapy - Nucleic Acids 22, pages 373-381.
Crossref
Mahin Khatami. (2020) Retracted: Deceptology in cancer and vaccine sciences: Seeds of immune destruction‐mini electric shocks in mitochondria: Neuroplasticity‐electrobiology of response profiles and increased induced diseases in four generations – A hypothesis. Clinical and Translational Medicine 10:8.
Crossref
Zili Gu, Candido Da Silva, Koen Van der Maaden, Ferry Ossendorp & Luis Cruz. (2020) Liposome-Based Drug Delivery Systems in Cancer Immunotherapy. Pharmaceutics 12:11, pages 1054.
Crossref
Satoshi Uchida, Federico Perche, Chantal Pichon & Horacio Cabral. (2020) Nanomedicine-Based Approaches for mRNA Delivery. Molecular Pharmaceutics 17:10, pages 3654-3684.
Crossref
Simone Putzke, Elisabeth Feldhues, Iris Heep, Thomas Ilg & Alf Lamprecht. (2020) Cationic lipid/pDNA complex formation as potential generic method to generate specific IRF pathway stimulators. European Journal of Pharmaceutics and Biopharmaceutics 155, pages 112-121.
Crossref
Rita Ahmed, Naya Sayegh, Michele Graciotti & Lana E. Kandalaft. (2020) Electroporation as a method of choice to generate genetically modified dendritic cell cancer vaccines. Current Opinion in Biotechnology 65, pages 142-155.
Crossref
Simone Hager, Frederic Julien Fittler, Ernst Wagner & Matthias Bros. (2020) Nucleic Acid-Based Approaches for Tumor Therapy. Cells 9:9, pages 2061.
Crossref
Christian D. Siewert, Heinrich Haas, Vera Cornet, Sara S. Nogueira, Thomas Nawroth, Lukas Uebbing, Antje Ziller, Jozef Al-Gousous, Aurel Radulescu, Martin A. Schroer, Clement E. Blanchet, Dmitri I. Svergun, Markus P. Radsak, Ugur Sahin & Peter Langguth. (2020) Hybrid Biopolymer and Lipid Nanoparticles with Improved Transfection Efficacy for mRNA. Cells 9:9, pages 2034.
Crossref
Jingjing Liu, Lei Miao, Jiying Sui, Yanyun Hao & Guihua Huang. (2020) Nanoparticle cancer vaccines: Design considerations and recent advances. Asian Journal of Pharmaceutical Sciences 15:5, pages 576-590.
Crossref
Yu Zhang, Tingting Shen, Shurong Zhou, Weinan Wang, Shuibin Lin & Guizhi Zhu. (2020) pH‐Responsive STING‐Activating DNA Nanovaccines for Cancer Immunotherapy. Advanced Therapeutics 3:9.
Crossref
Xinfu Zhang, Weiyu Zhao, Giang N. Nguyen, Chengxiang ZhangChunxi Zeng, Jingyue YanShi DuXucheng HouWenqing LiJustin JiangBinbin DengDavid W. McComb, Robert DorkinAalok Shah, Luis Barrera, Francine GregoireManmohan SinghDelai Chen, Denise E. Sabatino & Yizhou Dong. (2020) Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing. Science Advances 6:34.
Crossref
Shipra Malik, Anisha Gupta, Xiaobo Zhong, Theodore P. Rasmussen, Jose E. Manautou & Raman Bahal. (2020) Emerging Therapeutic Modalities against COVID-19. Pharmaceuticals 13:8, pages 188.
Crossref
Coral García-Fernández, Cristina Fornaguera & Salvador Borrós. (2020) Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy. Cancers 12:6, pages 1609.
Crossref
Lu Tan, Tao Zheng, Man Li, Xiaofang Zhong, Yao Tang, Ming Qin & Xun Sun. (2020) Optimization of an mRNA vaccine assisted with cyclodextrin-polyethyleneimine conjugates. Drug Delivery and Translational Research 10:3, pages 678-689.
Crossref
Margaret M. Billingsley, Nathan Singh, Pranali Ravikumar, Rui Zhang, Carl H. June & Michael J. Mitchell. (2020) Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering. Nano Letters 20:3, pages 1578-1589.
Crossref
Nicholas A. C. Jackson, Kent E. Kester, Danilo Casimiro, Sanjay Gurunathan & Frank DeRosa. (2020) The promise of mRNA vaccines: a biotech and industrial perspective. npj Vaccines 5:1.
Crossref
Céline Lacroix, Almudena Humanes, Céline Coiffier, Didier Gigmes, Bernard Verrier & Thomas Trimaille. (2020) Polylactide-Based Reactive Micelles as a Robust Platform for mRNA Delivery. Pharmaceutical Research 37:2.
Crossref
Abishek Wadhwa, Anas Aljabbari, Abhijeet Lokras, Camilla Foged & Aneesh Thakur. (2020) Opportunities and Challenges in the Delivery of mRNA-Based Vaccines. Pharmaceutics 12:2, pages 102.
Crossref
Sezer Okay, Öznur Özge Özcan & Mesut Karahan. (2020) Nanoparticle-based delivery platforms for mRNA vaccine development. AIMS Biophysics 7:4, pages 323-338.
Crossref
Yu Fang. (2020) An Overview of the Progress Made on the Coronavirus Vaccine. E3S Web of Conferences 185, pages 03042.
Crossref
Ramachandra Naik & Keith Peden. 2022. mRNA Vaccines. mRNA Vaccines 187 205 .
Chunxi Zeng, Chengxiang Zhang, Patrick G. Walker & Yizhou Dong. 2022. mRNA Vaccines. mRNA Vaccines 71 110 .
Camila dos Santos Meira & Lashitew Gedamu. (2019) Protective or Detrimental? Understanding the Role of Host Immunity in Leishmaniasis. Microorganisms 7:12, pages 695.
Crossref
Lien Van Hoecke & Kenny Roose. (2019) How mRNA therapeutics are entering the monoclonal antibody field. Journal of Translational Medicine 17:1.
Crossref
Cristina Poveda, Amadeo B. Biter, Maria Elena Bottazzi & Ulrich Strych. (2019) Establishing Preferred Product Characterization for the Evaluation of RNA Vaccine Antigens. Vaccines 7:4, pages 131.
Crossref
Sita Awasthi, Lauren M. Hook, Norbert PardiFushan WangArpita MylesMichael P. Cancro, Gary H. Cohen, Drew Weissman & Harvey M. Friedman. (2019) Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes. Science Immunology 4:39.
Crossref
Amal Bouraoui, Rosy Ghanem, Mathieu Berchel, Véronique Vié, Yann Le Guen, Gilles Paboeuf, Laure Deschamps, Tony Le Gall, Tristan Montier & Paul‐Alain Jaffrès. (2019) Bis‐Thioether‐Containing Lipid Chains in Cationic Amphiphiles: Physicochemical Properties and Applications in Gene Delivery. ChemPhysChem 20:17, pages 2187-2194.
Crossref
Federico Perche, Rudy Clemençon, Kai Schulze, Thomas Ebensen, Carlos A. Guzmán & Chantal Pichon. (2019) Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine. Molecular Therapy - Nucleic Acids 17, pages 767-775.
Crossref
John W. Loughney, Kevin Minsker, Sha Ha & Richard R. Rustandi. (2019) Development of an imaged capillary isoelectric focusing method for characterizing the surface charge of mRNA lipid nanoparticle vaccines. ELECTROPHORESIS 40:18-19, pages 2602-2609.
Crossref
Maria L. Guevara, Stefano Persano & Francesca Persano. (2019) Lipid-Based Vectors for Therapeutic mRNA-Based Anti-Cancer Vaccines. Current Pharmaceutical Design 25:13, pages 1443-1454.
Crossref
Gilles Besin, Jaclyn Milton, Staci Sabnis, Rebecca Howell, Cosmin Mihai, Kristine Burke, Kerry E. Benenato, Matthew Stanton, Peter Smith, Joseph Senn & Stephen Hoge. (2019) Accelerated Blood Clearance of Lipid Nanoparticles Entails a Biphasic Humoral Response of B-1 Followed by B-2 Lymphocytes to Distinct Antigenic Moieties. ImmunoHorizons 3:7, pages 282-293.
Crossref
Federico Perche, Tony Le Gall, Tristan Montier, Chantal Pichon & Jean-Marc Malinge. (2019) Cardiolipin-Based Lipopolyplex Platform for the Delivery of Diverse Nucleic Acids into Gram-Negative Bacteria. Pharmaceuticals 12:2, pages 81.
Crossref
Piotr S. Kowalski, Arnab Rudra, Lei Miao & Daniel G. Anderson. (2019) Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery. Molecular Therapy 27:4, pages 710-728.
Crossref
Anne-Line Coolen, Céline Lacroix, Perrine Mercier-Gouy, Emilie Delaune, Claire Monge, Jean-Yves Exposito & Bernard Verrier. (2019) Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation. Biomaterials 195, pages 23-37.
Crossref
Bin Li, Xinfu Zhang & Yizhou Dong. (2018) Nanoscale platforms for messenger RNA delivery. WIREs Nanomedicine and Nanobiotechnology 11:2.
Crossref
Eun Sook Lee, Jung Min Shin, Soyoung Son, Hyewon Ko, Wooram Um, Seok Ho Song, Jae Ah Lee & Jae Hyung Park. (2019) Recent Advances in Polymeric Nanomedicines for Cancer Immunotherapy. Advanced Healthcare Materials, pages 1801320.
Crossref
Siddharth PatelAvathamsa AthirasalaPaula P. MenezesN. AshwanikumarTing ZouGaurav SahayLuiz E. Bertassoni. (2019) Messenger RNA Delivery for Tissue Engineering and Regenerative Medicine Applications. Tissue Engineering Part A 25:1-2, pages 91-112.
Crossref
Lu Tan & Xun Sun. (2018) Recent advances in mRNA vaccine delivery. Nano Research 11:10, pages 5338-5354.
Crossref
Fazhan Wang, Wen Xiao, Mostafa A. Elbahnasawy, Xingting Bao, Qian Zheng, Linhui Gong, Yang Zhou, Shuping Yang, Aiping Fang, Mohamed M. S. Farag, Jinhui Wu & Xiangrong Song. (2018) Optimization of the Linker Length of Mannose-Cholesterol Conjugates for Enhanced mRNA Delivery to Dendritic Cells by Liposomes. Frontiers in Pharmacology 9.
Crossref
Bo-Eun Kim, Soon Won Choi, Ji-Hee Shin, Jae-Jun Kim, Insung Kang, Byung-Chul Lee, Jin Young Lee, Myoung Geun Kook & Kyung-Sun Kang. (2018) Single-Factor SOX2 Mediates Direct Neural Reprogramming of Human Mesenchymal Stem Cells via Transfection of In Vitro Transcribed mRNA . Cell Transplantation 27:7, pages 1154-1167.
Crossref
A. Le Moignic, V. Malard, T. Benvegnu, L. Lemiègre, M. Berchel, P.-A. Jaffrès, C. Baillou, M. Delost, R. Macedo, J. Rochefort, G. Lescaille, C. Pichon, F.M. Lemoine, P. Midoux & V. Mateo. (2018) Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells. Journal of Controlled Release 278, pages 110-121.
Crossref
Francesco Scorza & Norbert Pardi. (2018) New Kids on the Block: RNA-Based Influenza Virus Vaccines. Vaccines 6:2, pages 20.
Crossref
Norbert Pardi, Michael J. Hogan, Frederick W. Porter & Drew Weissman. (2018) mRNA vaccines — a new era in vaccinology. Nature Reviews Drug Discovery 17:4, pages 261-279.
Crossref
Blaise Corthésy & Gilles Bioley. (2018) Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection. Frontiers in Immunology 9.
Crossref
S. Sohail Ahmed, Ronald W. Ellis & Rino Rappuoli. 2018. Plotkin's Vaccines. Plotkin's Vaccines 1283 1304.e7 .
Marc P. Girard & Wayne C. Koff. 2018. Plotkin's Vaccines. Plotkin's Vaccines 400 429.e25 .
Nily Dan. 2018. Lipid Nanocarriers for Drug Targeting. Lipid Nanocarriers for Drug Targeting 529 562 .
Man Li, You Li, Ke Peng, Ying Wang, Tao Gong, Zhirong Zhang, Qin He & Xun Sun. (2017) Engineering intranasal mRNA vaccines to enhance lymph node trafficking and immune responses. Acta Biomaterialia 64, pages 237-248.
Crossref
Kai Shi, Matthew Haynes & Leaf Huang. (2017) Nanovaccines for remodeling the suppressive tumor microenvironment: New horizons in cancer immunotherapy. Frontiers of Chemical Science and Engineering 11:4, pages 676-684.
Crossref
Rein Verbeke, Ine Lentacker, Laura Wayteck, Karine Breckpot, Mieke Van Bockstal, Benedicte Descamps, Christian Vanhove, Stefaan C. De Smedt & Heleen Dewitte. (2017) Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA. Journal of Controlled Release 266, pages 287-300.
Crossref
Khalid A. Hajj & Kathryn A. Whitehead. (2017) Tools for translation: non-viral materials for therapeutic mRNA delivery. Nature Reviews Materials 2:10.
Crossref
Owen S. Fenton, Kevin J. Kauffman, James C. Kaczmarek, Rebecca L. McClellan, Siddharth Jhunjhunwala, Mark W. Tibbitt, Manhao D. Zeng, Eric A. Appel, Joseph R. Dorkin, Faryal F. Mir, Jung H. Yang, Matthias A. Oberli, Michael W. Heartlein, Frank DeRosa, Robert Langer & Daniel G. Anderson. (2017) Synthesis and Biological Evaluation of Ionizable Lipid Materials for the In Vivo Delivery of Messenger RNA to B Lymphocytes. Advanced Materials 29:33.
Crossref
Matthias A. Oberli, Andreas M. Reichmuth, J. Robert Dorkin, Michael J. Mitchell, Owen S. Fenton, Ana Jaklenec, Daniel G. Anderson, Robert Langer & Daniel Blankschtein. (2016) Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Letters 17:3, pages 1326-1335.
Crossref
S Guan & J Rosenecker. (2017) Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems. Gene Therapy 24:3, pages 133-143.
Crossref
Zhao Meng, Jonathan O'Keeffe-Ahern, Jing Lyu, Luca Pierucci, Dezhong Zhou & Wenxin Wang. (2017) A new developing class of gene delivery: messenger RNA-based therapeutics. Biomaterials Science 5:12, pages 2381-2392.
Crossref
B. Pitard & D. Habrant. 2017. Comprehensive Supramolecular Chemistry II. Comprehensive Supramolecular Chemistry II 365 389 .
Norbert Pardi & Drew Weissman. 2017. RNA Vaccines. RNA Vaccines 143 153 .
Susanne Rauch, Johannes Lutz, Aleksandra Kowalczyk, Thomas Schlake & Regina Heidenreich. 2017. RNA Vaccines. RNA Vaccines 89 107 .
Ans De Beuckelaer, Charlotte Pollard, Sandra Van Lint, Kenny Roose, Lien Van Hoecke, Thomas Naessens, Vimal Kumar Udhayakumar, Muriel Smet, Niek Sanders, Stefan Lienenklaus, Xavier Saelens, Siegfried Weiss, Guido Vanham, Johan Grooten & Stefaan De Koker. (2016) Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses. Molecular Therapy 24:11, pages 2012-2020.
Crossref
Kevin J. Kauffman, Matthew J. Webber & Daniel G. Anderson. (2016) Materials for non-viral intracellular delivery of messenger RNA therapeutics. Journal of Controlled Release 240, pages 227-234.
Crossref
Nathan J. Oldenhuis, Alexander C. Eldredge, Alan O. Burts, Keun Ah Ryu, Jae Chung, Mark E. Johnson & Zhibin Guan. (2016) Biodegradable Dendronized Polymers for Efficient mRNA Delivery. ChemistrySelect 1:15, pages 4413-4417.
Crossref
Cristine Gonçalves, Sohail Akhter, Chantal Pichon & Patrick Midoux. (2016) Intracellular Availability of pDNA and mRNA after Transfection: A Comparative Study among Polyplexes, Lipoplexes, and Lipopolyplexes. Molecular Pharmaceutics 13:9, pages 3153-3163.
Crossref
Jeffrey B Ulmer & Andrew J Geall. (2016) Recent innovations in mRNA vaccines. Current Opinion in Immunology 41, pages 18-22.
Crossref
O. V. Sergeeva, V. E. Koteliansky & T. S. Zatsepin. (2016) mRNA-based therapeutics–Advances and perspectives. Biochemistry (Moscow) 81:7, pages 709-722.
Crossref
Andreas M Reichmuth, Matthias A Oberli, Ana Jaklenec, Robert Langer & Daniel Blankschtein. (2016) mRNA vaccine delivery using lipid nanoparticles. Therapeutic Delivery 7:5, pages 319-334.
Crossref
Man Li, Mengnan Zhao, Yao Fu, You Li, Tao Gong, Zhirong Zhang & Xun Sun. (2016) Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways. Journal of Controlled Release 228, pages 9-19.
Crossref
Kristin H. Loomis, Jonathan L. Kirschman, Sushma Bhosle, Ravi V. Bellamkonda & Philip J. Santangelo. (2016) Strategies for modulating innate immune activation and protein production of in vitro transcribed mRNAs. Journal of Materials Chemistry B 4:9, pages 1619-1632.
Crossref
Norbert Pardi, Steven Tuyishime, Hiromi Muramatsu, Katalin Kariko, Barbara L. Mui, Ying K. Tam, Thomas D. Madden, Michael J. Hope & Drew Weissman. (2015) Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. Journal of Controlled Release 217, pages 345-351.
Crossref
Mohammad Ariful Islam, Emma K. G. Reesor, Yingjie Xu, Harshal R. Zope, Bruce R. Zetter & Jinjun Shi. (2015) Biomaterials for mRNA delivery. Biomaterials Science 3:12, pages 1519-1533.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.